Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both or neither. Jones RJ, DeBaun MR. Blood 2021 Jun 3. pii: 476065. doi: 10.1182/blood.2021011488.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jones RJ, DeBaun MR. Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both or neither. Blood 2021 Jun 3. pii: 476065. doi: 10.1182/blood.2021011488.
PMID: 34115136